Risedronic Acid clinical trials
Also written Risedronate.
How each study uses Risedronic Acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Risedronic Acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 27 Mar 1998 · ACTONEL · NDA 020835 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
71 studies that test it; most in 2004 (12); 1 more planned to start later
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 9 |
| 2003 | 9 |
| 2004 | 12 |
| 2005 | 3 |
| 2006 | 6 |
| 2007 | 7 |
| 2008 | 4 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 35 · Other 38
Warner Chilcott (15) · Sanofi (15) · Wake Forest University Health Sciences (4) · University of Nebraska (2) · Massachusetts General Hospital (2) · Hanlim Pharm. Co., Ltd. (2) · Alliance for Clinical Trials in Oncology (2) · Toronto Rehabilitation Institute (2)
Often tested with
Tested in the same studies.
Cholecalciferol (2) · Camrelizumab (1) · Vitamin D (1) · Testosterone (1) · Mecasermin (1) · Ibandronic Acid (1) · Alendronate (1) · Parathyroid Hormone (1)
Related medicines
As reviewed, each with the page that says it.
- One of Diphosphonates source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Risedronic Acid.
- Jan 2027Effects of Bisphosphonates on OI-Related Hearing LossPhase 4 · Hospital for Special Surgery, New York
Studies
Open first, then newest update. How each study uses Risedronic Acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 73
- Fighting Osteoporosis With Risedronate Co-Therapy During IncretinNot yet recruitingPhase 3Wake Forest University Health SciencesNCT07943754Written as RisedronateHow we know
- Effects of Bisphosphonates on OI-Related Hearing LossRecruitingPhase 4Hospital for Special Surgery, New YorkNCT04152551Written as Risedronate Oral TabletHow we know
- Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric SurgeryRecruitingPhase 3Wake Forest University Health SciencesNCT04922333Written as RisedronateHow we know
- Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRTCompletedPhase 2Wake Forest University Health SciencesNCT03861091Written as risedronateHow we know
- Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and EfficacyActive, not recruitingPhase 2Harbin Medical UniversityNCT07471815Written as Camrelizumab + Risedronate Sodium + ChemotherapyHow we know
- Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis WomenCompletedPhase 4Dong-A ST Co., Ltd.NCT05630768Written as Risedronate Sodium 35 MG [Actonel]How we know
- Prevention of Osteoporosis in Breast Cancer SurvivorsCompletedNot applicableUniversity of NebraskaNCT00567606Written as Drug/Supplement onlyHow we know
- Heartland Osteoporosis Prevention StudyCompletedPhase 3University of NebraskaNCT02186600Written as RisedronateHow we know
- Effect of Actonel on Periodontal Health of Postmenopausal WomenWithdrawnPhase 4University Hospitals Cleveland Medical CenterNCT00594334Written as RisedronateHow we know
- Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal PatientsCompletedNot applicableHospital Regional 1o de OctubreNCT05346419Written as RisedronateHow we know
- Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of BoneCompletedPhase 2/3Institut National de la Santé Et de la Recherche Médicale, FranceNCT00445575Written as risedronateHow we know
- Effects of Bisphosphonates and Nutritional Supplementation After a Hip FractureCompletedNot applicableKarolinska InstitutetNCT01950169Written as RisedronateHow we know
- Weight Loss With Risedronate for Bone HealthCompletedPhase 4Wake Forest University Health SciencesNCT03411902Written as Risedronate Sodium 150 MGHow we know
- A Study of Actonel for the Prevention of Bone LossCompletedPhase 3M.D. Anderson Cancer CenterNCT00452439Written as Actonel (Risedronate)How we know
- Bone Loss in Women With Anorexia NervosaCompletedPhase 2/3Massachusetts General HospitalNCT00089843Written as Actonel (risedronate)How we know
- IGF-1 and Bone Loss in Women With Anorexia NervosaCompletedNot applicableMassachusetts General HospitalNCT01406444Written as RisedronateHow we know
- Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With OsteoporosisCompletedPhase 4Hanlim Pharm. Co., Ltd.NCT01675297Written as Risedronate/Cholecalciferol combinationHow we know
- Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.CompletedPhase 1/2Montefiore Medical CenterNCT00266708Written as RisedronateHow we know
- Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip ProthesisTerminatedPhase 3University Hospital, LimogesNCT02744482Written as risedronateHow we know
- Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta?CompletedPhase 2Sheffield Children's NHS Foundation TrustNCT03208582Written as Risedronate SodiumHow we know
See all 73 studies that test Risedronic Acid →
As the comparator · 12 — what is tested is compared with Risedronic Acid
- Bone Turnover Markers and Treatment Efficacy in Postmenopausal OsteoporosisCompletedNot applicableKhyber Medical University PeshawarNCT07242612Written as Alendronate, Ibandronate; RisedronateHow we know
- A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)CompletedPhase 3Organon and CoNCT00092014Written as Risedronate 35 mgHow we know
- Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate TherapyCompletedPhase 3AmgenNCT00919711Written as Actonel®How we know
- A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip FractureCompletedPhase 4Eli Lilly and CompanyNCT00887354Written as RisedronateHow we know
- VERtebral Fracture Treatment Comparisons in Osteoporotic WomenCompletedPhase 4Eli Lilly and CompanyNCT01709110Written as RisedronateHow we know
- A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.CompletedPhase 4Hoffmann-La RocheNCT00377234Written as RisedronateHow we know
- Post-menopausal Women Osteoporosis(Phase III)CompletedPhase 3Hanlim Pharm. Co., Ltd.NCT01806792Written as RisedronateHow we know
- Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM)CompletedPhase 3TakedaNCT00365456Written as RisedronateHow we know
- Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation PeriodCompletedPhase 3Novartis PharmaceuticalsNCT00103740Written as RisedronateHow we know
- Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation PeriodCompletedPhase 3Novartis PharmaceuticalsNCT00051636Written as RisedronateHow we know
- Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced OsteoporosisCompletedPhase 3Eli Lilly and CompanyNCT00503399Written as RisedronateHow we know
- Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by OsteoporosisCompletedPhase 3Eli Lilly and CompanyNCT00343252Written as risedronateHow we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Newly registered1
- Fighting Osteoporosis With Risedronate Co-Therapy During IncretinNov 17, 2026NCT07943754
Codes
What other systems call Risedronic Acid · ClinicalTrials.gg INT006506
- MeSH (NLM) D000068296Risedronic AcidConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) KM2Z91756ZRISEDRONIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 73056Confirmed FDA, Wikidata
- Wikidata Q408724risedronic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66517Risedronic AcidConfirmed FDA, Wikidata
- DrugBank DB00884One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000068296 | Risedronic Acid | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | KM2Z91756Z | RISEDRONIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 73056 | — | Confirmed FDA, Wikidata |
| Wikidata | Q408724 | risedronic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66517 | Risedronic Acid | Confirmed FDA, Wikidata |
| DrugBank | DB00884 | — | One source Wikidata |
Also registered as risedronate sodium (UNII OFG5EXG60L · RxNorm 60334).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.